Healthy Extracts (HYEX) Cash from Investing Activities (2015 - 2025)
Healthy Extracts' (HYEX) quarterly Cash from Investing Activities came in at $75603.0 in Q4 2025, up 491.68% quarter-over-quarter from -$19302.0 in Q2 2025.
Healthy Extracts (HYEX) Cash from Investing Activities (2015 - 2025) Analysis & Trends
Healthy Extracts' Cash from Investing Activities history runs 8 years deep, the most recent figure standing at $75603.0 for Q4 2025.
- On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to $75603.0 in Q4 2025; TTM through Dec 2025 was $56301.0, a N/A change from a year earlier, with the FY2025 full-year figure at $56301.0, changed N/A from the prior year.
- Cash from Investing Activities improved to $75603.0 in Q4 2025 per HYEX's latest filing, from -$19302.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $75603.0 in Q4 2025 and bottomed at -$37888.0 in Q1 2021.
- The 3-year median for Cash from Investing Activities is -$11308.0 (2021), against an average of -$5630.9.
- Across the five-year window, Cash from Investing Activities jumped 69.32% in 2021 and jumped 107.45% in 2022, its largest moves.
- Year by year, Cash from Investing Activities stood at -$11116.0 in 2021, then surged by 123.78% to $2643.0 in 2022, then jumped by 2760.5% to $75603.0 in 2025.
- Per Business Quant, the three latest HYEX Cash from Investing Activities figures stand at $75603.0 (Q4 2025), -$19302.0 (Q2 2025), and $2643.0 (Q2 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.82 Bn | 87.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.03 Bn | 32.29 Bn | 1.97 Bn | 229.00 Mn |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | -87.00 Mn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn | -369.95 Mn |
| 5 | United Therapeutics | 23.02 Bn | 20.86 Bn | 648.10 Mn | 743.70 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.43 Bn | 18.63 Bn | 1.16 Bn | 277.40 Mn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | -506.20 Mn |
| 9 | Elanco Animal Health | 12.73 Bn | 12.30 Bn | 785.00 Mn | -60.00 Mn |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | 75,603.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75,603.00 |
| Dec 31, 2025 | 75,603.00 |
| Jun 30, 2025 | -19,302.00 |
| Jun 30, 2025 | -19,302.00 |
| Jun 30, 2022 | 2,643.00 |
| Jun 30, 2022 | 2,643.00 |
| Mar 31, 2022 | -7,987.00 |
| Mar 31, 2022 | -7,987.00 |
| Dec 31, 2021 | -11,116.00 |
| Dec 31, 2021 | -11,116.00 |
| Sep 30, 2021 | -11,500.00 |
| Sep 30, 2021 | -11,500.00 |
| Jun 30, 2021 | -35,500.00 |
| Jun 30, 2021 | -35,500.00 |
| Mar 31, 2021 | -37,888.00 |
| Mar 31, 2021 | -37,888.00 |
| Dec 31, 2020 | -51,500.00 |
| Dec 31, 2020 | -51,500.00 |
| Sep 30, 2020 | -37,486.00 |
| Sep 30, 2020 | -37,486.00 |